IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis

Ann Rheum Dis. 2009 Oct;68(10):1652-3. doi: 10.1136/ard.2008.103184.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Autoantibodies / blood*
  • Biomarkers / blood
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin M / blood
  • Male
  • Middle Aged
  • Peptides, Cyclic / immunology*
  • Rheumatoid Factor / blood

Substances

  • Antirheumatic Agents
  • Autoantibodies
  • Biomarkers
  • Immunoglobulin M
  • Peptides, Cyclic
  • cyclic citrullinated peptide
  • Rheumatoid Factor

Associated data

  • ISRCTN/ISRCTN96372677